Sen. Ted Budd

Maddy summaryThis bill expands Medicare coverage for obesity treatment. It allows more healthcare providers - including nurse practitioners, dietitians, and clinical psychologists - to offer intensive behavioral therapy for obesity, with requirements for coordination with primary care physicians. It also adds Medicare Part D coverage for FDA-approved medications used to treat obesity or manage weight in adults with related health conditions (like diabetes or high blood pressure). These changes directly affect Medicare beneficiaries with obesity, aiming to improve access to proven treatment options. The bill requires annual reports to Congress on implementation progress.

Maddy summaryThe PELL Act (S 2442) creates a new "Workforce Pell Grants" program under the Higher Education Act, providing federal grants to students enrolled in short-term, career-focused training programs. It directly affects students seeking workforce credentials (not full degrees) and institutions offering qualifying programs that meet strict criteria: programs must be 150-600 clock hours (8-15 weeks), lead to industry-aligned credentials, achieve 70% completion and job placement rates, and have tuition costs tied to verified student earnings data. The bill requires the Department of Education to collect and publish annual data on program outcomes, including completion rates, job placement, and 3-year median earnings for graduates. This program replaces traditional Pell Grants for these specific short-term programs starting July 2024, with no double-benefits allowed for the same enrollment period.

Maddy summaryS 2430 amends the 1986 Emergency Planning and Community Right-To-Know Act to exclude certain air emissions from animal waste at farms from emergency notification requirements. This bill directly affects agricultural operations that handle animal waste, removing a requirement to report specific airborne emissions to emergency planners and the public. The key provision adds a new exception (B) to the notification rules, explicitly excluding "air emissions from animal waste (including decomposing waste) at a farm" as defined under related environmental law. This change simplifies reporting obligations for farms while maintaining other emergency planning requirements under the Act.

Maddy summaryThis bill, S 2396, prohibits debt collectors from threatening servicemembers or their eligible dependents with rank reduction, security clearance revocation, or military prosecution (under the Uniform Code of Military Justice) when collecting debts. It directly affects active-duty service members, recent veterans (within 365 days of separation), and their dependents as defined in the bill. Key provisions amend the Fair Debt Collection Practices Act to ban these specific threats in debt collection communications and representations. The bill also requires a Government Accountability Office (GAO) study to assess its impact on military readiness, national security, and timely information delivery to covered members.

Maddy summaryS 2372, the Accelerating Kids’ Access to Care Act, streamlines enrollment for out-of-state healthcare providers who treat Medicaid-eligible children under 21 with medically complex conditions. It requires states to adopt a process allowing these providers to join state Medicaid/CHIP programs without extra state-level screening, provided they already meet federal Medicare or home-state program requirements and pose low fraud risk. The bill establishes a 5-year enrollment period for eligible providers, directly affecting children needing specialized care across state lines and the providers serving them. Key provisions remove barriers to interstate care coordination while maintaining federal oversight standards.

Maddy summaryThis bill requires the Assistant Secretary for Preparedness and Response (within HHS) to assess how emerging AI technologies - like open-source models and large language models - could be misused to develop biological weapons, viruses, or chemical weapons. It mandates regular monitoring of global biological risks that could cause mass casualties or destabilize societies, and directs the inclusion of these findings in the National Health Security Strategy. The law directly affects federal health security planning by adding this specific AI-biosecurity risk assessment to existing public health responsibilities. It creates a new procedural requirement for federal agencies to evaluate and report on these emerging threats.

Maddy summaryThis bill requires the Secretary of Health and Human Services to develop and submit a strategy within 180 days of enactment to address public health risks from AI misuse. The strategy must cover threats like AI-facilitated biological weapons development and engineered pathogens, identify gaps in current capabilities, and outline how to strengthen emergency response. It mandates coordination with stakeholders developing health countermeasures and integrates AI threats into existing public health emergency planning under the Public Health Service Act. The bill directly affects HHS, public health agencies, and health technology developers, focusing on concrete policy coordination rather than new funding or regulations.

Maddy summaryS 2330, the Small Business Technological Advancement Act, expands eligibility for Small Business Administration (SBA) loans to cover business software and cloud computing services. It directly affects small businesses seeking to finance tools that manage payroll, human resources, sales, billing, inventory, or accounting operations. The bill amends Section 7(a) of the Small Business Act to explicitly allow SBA loans to partially or fully fund these technology services. This changes existing policy by broadening the types of business expenses covered under standard SBA loan programs.

Maddy summaryThis bill requires the U.S. Department of Health and Human Services to update safety guidelines for gene synthesis providers within one year of enactment. It mandates screening for dangerous DNA sequences, verifying customer identities, using approved software tools, and maintaining detailed records of orders and screening results. The law directly affects companies that synthesize custom DNA (like gene sequences for research or medicine), equipment manufacturers, and software developers in this field. Key provisions include creating a public list of "sequences of concern" for screening and providing technical assistance to help companies comply with the new requirements.

Maddy summaryS 2329 establishes a new FDA program to accelerate the development of medical tools (like vaccines and treatments) for emerging infectious diseases. The program will fund research on safety standards, maintain disease surveillance, ensure blood supply safety, and prioritize platform vaccine technologies for faster emergency use. It authorizes $60 million annually from 2024 to 2028 to support these activities through grants and contracts. The bill does not change the FDA’s existing authority to approve or authorize medical products under current law.